Currently, only two manufacturers are making generic semaglutide available for purchase in Canada
The increasing prevalence of obesity worldwide and its associated pressure on healthcare systems, along with the reputation of GLP-1 drugs for inducing significant weight loss (approximately 1525+%, significantly higher than previous generations of obesity drugs), are driving GLP-1 drug expansion into new markets like China
For patients experiencing acid reflux symptoms while taking Zepbound, several evidence-based management strategies can provide relief without necessarily requiring medication discontinuation
Tirzepatide Weight Loss is an FDA-approved, non-surgical treatment designed to help individuals achieve effective and sustainable weight loss
It is a narrative review of the literature focused on physical medicine and rehabilitation, not a randomized controlled trial, systematic review, or meta-analysis
I mean, we talk about lifespan decliningfor the first time since records have been keptover the past 5 years quite significantly